Karriereverlauf von Mike Holfinger
Ehemalige bekannte Positionen von Mike Holfinger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALEXZA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.06.2013 | 01.06.2013 |
AFFYMAX, INC. | Corporate Officer/Principal | 01.06.2006 | 01.06.2013 |
AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 08.04.2015 | - |
Ausbildung von Mike Holfinger
University of Wisconsin | Doctorate Degree |
Miami University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AFFYMAX, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
- Börse
- Insiders
- Mike Holfinger
- Erfahrung